Table 3.

List of isolates with putative compensatory mutations that affect the properties of the bridge helix

Rifampicin resistance mutationSecondary RNA polymerase mutationOrganismCompensationaReference
rpoB Q513PrpoB R633LM. tuberculosisND49
rpoB H526DrpoB D626EM. tuberculosisND49
rpoB H526RrpoB D626EM. tuberculosisND49
rpoB R529CrpoB R637CS. typhimuriumyes48
rpoB R529CrpoB H673YS. typhimuriumyes48
rpoB R529CrpoC L770PS. typhimuriumyes48
rpoB S531LrpoB I603MM. tuberculosisND49
rpoB S531LrpoB V615MM. tuberculosisyesthis study
Rifampicin resistance mutationSecondary RNA polymerase mutationOrganismCompensationaReference
rpoB Q513PrpoB R633LM. tuberculosisND49
rpoB H526DrpoB D626EM. tuberculosisND49
rpoB H526RrpoB D626EM. tuberculosisND49
rpoB R529CrpoB R637CS. typhimuriumyes48
rpoB R529CrpoB H673YS. typhimuriumyes48
rpoB R529CrpoC L770PS. typhimuriumyes48
rpoB S531LrpoB I603MM. tuberculosisND49
rpoB S531LrpoB V615MM. tuberculosisyesthis study

ND, not determined.

aSecondary mutation experimentally shown to compensate the fitness cost caused by the rifampicin resistance mutation.

Table 3.

List of isolates with putative compensatory mutations that affect the properties of the bridge helix

Rifampicin resistance mutationSecondary RNA polymerase mutationOrganismCompensationaReference
rpoB Q513PrpoB R633LM. tuberculosisND49
rpoB H526DrpoB D626EM. tuberculosisND49
rpoB H526RrpoB D626EM. tuberculosisND49
rpoB R529CrpoB R637CS. typhimuriumyes48
rpoB R529CrpoB H673YS. typhimuriumyes48
rpoB R529CrpoC L770PS. typhimuriumyes48
rpoB S531LrpoB I603MM. tuberculosisND49
rpoB S531LrpoB V615MM. tuberculosisyesthis study
Rifampicin resistance mutationSecondary RNA polymerase mutationOrganismCompensationaReference
rpoB Q513PrpoB R633LM. tuberculosisND49
rpoB H526DrpoB D626EM. tuberculosisND49
rpoB H526RrpoB D626EM. tuberculosisND49
rpoB R529CrpoB R637CS. typhimuriumyes48
rpoB R529CrpoB H673YS. typhimuriumyes48
rpoB R529CrpoC L770PS. typhimuriumyes48
rpoB S531LrpoB I603MM. tuberculosisND49
rpoB S531LrpoB V615MM. tuberculosisyesthis study

ND, not determined.

aSecondary mutation experimentally shown to compensate the fitness cost caused by the rifampicin resistance mutation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close